DSD-C249

46,XY DSD — disordered gonadal/androgen synthesis (17α-hydroxylase deficiency). · 46,XY · DSD-C249

DSD-C249 · 46,XY DSD — disordered gonadal/androgen synthesis (17α-hydroxylase deficiency).

Karyotype 46,XY · Phenotypes HPO:0000028, HPO:0000047, HPO:0000054, HPO:0000062, HPO:0000771, Micropenis (HP:0000054), Ambiguous genitalia (HP:0000062), Hypospadias (HP:0000047), Cryptorchidism (HP:0000028), Gynecomastia (HP:0000771)

46,XY male pseudohermaphroditism, etiologically established by steroid studies as partial 17α-hydroxylase deficiency (secretion rates of corticosterone/DOC ~7–8× normal, cortisol/S/aldosterone very low).

Images · 1

Case fields and evidence

Category

46,XY DSD — disordered gonadal/androgen synthesis (17α-hydroxylase deficiency).

Age

24 years (at presentation; diagnosed male pseudohermaphroditism at 20 months; marked gynecomastia since age 16).

Sex

Rearing sex male (ambiguous genitalia at birth; assigned male at 20 months and raised as male).

Karyotype

46,XY

Phenotypes

Micropenis (HP:0000054); Ambiguous genitalia (HP:0000062); Hypospadias (HP:0000047); Cryptorchidism (HP:0000028); Gynecomastia (HP:0000771)

Diagnosis

46,XY male pseudohermaphroditism, etiologically established by steroid studies as partial 17α-hydroxylase deficiency (secretion rates of corticosterone/DOC ~7–8× normal, cortisol/S/aldosterone very low).

Follow-up

Off-testosterone 17-KS rose; long-term testosterone maintenance with good virilization.

General phenotype

Eunuchoid habitus, no temporal hair recession, smooth skin, no acne/seborrhea; high-pitched voice; marked gynecomastia, absence of virilization; no severe hypertension or hypokalemia.

Imaging

IVP showed unusual bladder neck; retrograde/voiding cystogram showed irregular distal urethra and bulbous mid-urethral dilation; wrist film showed epiphyseal fusion (without changes attributable to androgen/estrogen deficiency).

Laboratory findings

Low urinary 17-KS and 17-OHCS unresponsive to ACTH; plasma testosterone persistently in female range (no rise with ACTH/hCG/dexamethasone); plasma DHEA below normal; markedly elevated gonadotropins (FSH 106, LH 364 mIU/ml); very low plasma renin (0.1 ng/ml/h) and low aldosterone; aldosterone rose acutely after ACTH.

Management

Infancy methyltestosterone orally + testosterone ointment increased phallic length (2.5→3.2 cm); multiple urologic operations for hypospadias/chordee; mastectomy in teens; long-term IM testosterone enanthate/propionate with virilization within 6 weeks (deepened voice, seborrhea, pubic/facial hair, increased strength).

Pathology

Testicular biopsy showed Leydig-cell hyperplasia and early spermatogenesis; breast biopsy showed ducts and acini; vaginal-wall biopsy showed stratified squamous epithelium; removed testes showed tubules lined almost entirely by Sertoli cells with relative Leydig-cell increase.

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Genetics

See source

Cite this resource

DSD Research Library | 46,XY DSD — disordered gonadal/androgen synthesis (17α-hydroxylase deficiency). · 46,XY · DSD-C249 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C249?version=v1.4.0